Intervention Review

Drug treatment for myotonia

  1. Jeroen Trip1,*,
  2. Gea G Drost2,
  3. Baziel GM van Engelen3,
  4. C G Faber4

Editorial Group: Cochrane Neuromuscular Group

Published Online: 25 JAN 2006

Assessed as up-to-date: 29 JUL 2009

DOI: 10.1002/14651858.CD004762.pub2

How to Cite

Trip J, Drost GG, van Engelen BGM, Faber CG. Drug treatment for myotonia. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD004762. DOI: 10.1002/14651858.CD004762.pub2.

Author Information

  1. 1

    Diaconessenhuis Meppel, Neurologist, Meppel, Netherlands

  2. 2

    Radboud University Nijmegen Medical Center, Department of Neurophysiology, Nijmegen, Netherlands

  3. 3

    Radboud University Nijmegen Medical Center, Neuromuscular Center Nijmegen, Nijmegen, Netherlands

  4. 4

    MUML, Department Neurology, Maastricht, Netherlands

*Jeroen Trip, Neurologist, Diaconessenhuis Meppel, Hoogeveenseweg 38, Meppel, 7943 KA, Netherlands.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 25 JAN 2006


  1. Current Version

    Drug treatment for myotonia

    Jeroen Trip, Gea G Drost, Baziel GM van Engelen and C G Faber

    Version of Record online: 25 JAN 2006 | DOI: 10.1002/14651858.CD004762.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Drug treatment for myotonia

    J Trip, BGM van Engelen, G Drost and CG Faber

    Version of Record online: 19 APR 2004 | DOI: 10.1002/14651858.CD004762